Dean L Schorno
CIK 1509688 · EVP & Chief Financial Officer · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.55M
Companies
2
Total Filings
61
Lifetime Open-Market Net
-$1.82M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RIGL | EVP & Chief Financial Officer | 77,537 | $32.85 | $2.55M | $2.6K | 28 | 2026-06-03 |
| GENOMIC HEALTH INC (GHDX) Delisted | CFO | 29,963 | — | — | -$1.82M | 33 | 2014-02-19 |
Recent Filings · Page 2 of 7
61 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-04 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2024-03-01 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2024-02-06 | RIGL | Sell (S) | −12,628 | -$14.3K | EDGAR |
| 2024-01-25 | RIGL | Grant (A) | +209,000 | $0 | EDGAR |
| 2023-02-06 | RIGL | Sell (S) | −5,389 | -$8.9K | EDGAR |
| 2023-01-30 | RIGL | Grant (A) | +63,000 | $0 | EDGAR |
| 2022-12-30 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2022-09-16 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2022-01-26 | RIGL | Grant (A) | +50,000 | $0 | EDGAR |
| 2021-11-05 | RIGL | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.